Journal profile · Pathology
Diagnostic Cytopathology
ISSN 8755-1039 · eISSN 1097-0339 · Wiley-Liss Inc. · UNITED STATES · Monthly · Founded 1985
Diagnostic Cytopathology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.93; hybrid open access; APC about USD 3,920; median 73 days to acceptance (91 articles, last 24 months); community-reported acceptance: easy; 162 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diagnostic Cytopathology is published by Wiley-Liss Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Salivary Gland Tumors Diagnosis and Treatment, Cervical Cancer and HPV Research and Breast Lesions and Carcinomas, together about 25.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Diagnostic Cytopathology is intended to provide a forum for the exchange of information in the field of cytopathology, with special emphasis on the practical, clinical aspects of the discipline. The editors invite original scientific articles, as well as special review articles, feature articles, and letters to the editor, from laboratory professionals engaged in the practice of cytopathology. Manuscripts are accepted for publication on the basis of scientific merit, practical significance, and suitability for publication in a journal dedicated to this discipline. Original articles can be considered only with the understanding that they have never been published before and that they have not been submitted for simultaneous review to another publication.
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Zubair BalochPublisher website
Editorial board by country: none in mainland China; most named India 3, Taiwan, China 2, France 2, Italy 2, Spain 2 (24 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Salivary Gland Tumors Diagnosis and TreatmentMedicine10.1%
- Cervical Cancer and HPV ResearchMedicine8.9%
- Breast Lesions and CarcinomasMedicine6.3%
- Cancer and Skin LesionsMedicine6%
- Thyroid Cancer Diagnosis and TreatmentMedicine5.9%
- Sarcoma Diagnosis and TreatmentMedicine5.6%
- Pancreatic and Hepatic Oncology ResearchMedicine4.4%
- Neuroendocrine Tumor Research AdvancesMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 3 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medical Laboratory Technology | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.93LetPub ·
- Impact factor (publisher)
- 0.9Publisher website ·
- Impact factor (publisher) 2025
- 0.9Publisher website ·
- CiteScore 2026-06
- 2LetPub ·
- CiteScore (publisher)
- 2Publisher website ·
- CiteScore (publisher) 2025
- 2Publisher website ·
- SJR 2026-06
- 0.33LetPub ·
- SNIP 2026-06
- 0.57LetPub ·
- h-index
- 61LetPub ·
- h-index
- 90OpenAlex ·
- i10-index
- 3,615OpenAlex ·
- 2-year mean citedness
- 0.88OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 22.12%LetPub ·
Volume
- Articles per year
- 129LetPub ·
- Articles per year (publisher) 2025
- 137Publisher website ·
- Downloads per year (publisher) 2025
- 153,757Publisher website ·
Articles by year OpenAlex count · 8,644 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 151 | 79 | 14 |
| 2025 | 162 | 82 | 141 |
| 2024 | 182 | 98 | 283 |
| 2023 | 185 | 99 | 498 |
| 2022 | 182 | 26 | 731 |
| 2021 | 237 | 21 | 1,196 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
73 daysMedian, submission to acceptance · P25–P75 51 days – 103 days
- Acceptance to online
- median 9 days (91 articles)
- Submission to online
- median 85 days
- Sample
- 91 articles with submission and acceptance dates (327 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 25%Publisher website ·
- Acceptance rate (publisher) 2025
- 25%Publisher website ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to first decision 2025
- 5 daysPublisher website ·
- Submission to acceptance 2025
- 82 daysPublisher website ·
- Acceptance to publication 2025
- 8 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,920 / EUR 3,240 / GBP 2,620 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
Article types accepted8
- book reviewBook Review. Reviews of newly-published text-books, atlases and monographs dedicated to cytopathology and its related disciplines.Length not stated
- brief reportBrief Report. Report of a single case or a small series (fewer than 12) with unique content and exceptional clarity.Length not stated
- editorialEditorial. Recognized leaders in the field of cytopathology may offer their opinions regarding an article or a group of related papers appearing in the same iss…Length not stated
- images in cytologyImages in Cytology. Rely on the visual singularity of their illustrations to call attention to a rare condition or provide exceptionally classical examples of a…Length not stated
- letter to the editorLetter to the Editor. Commentaries in response to a recently published article, or focused, timely communications of immediate interest to the readership.Length not stated
- molecular cytopathologyMolecular Cytopathology. Describe original observations based on translational research, molecular testing, and the identification of targets for novel forms of…Length not stated
- original articleOriginal Article. Studies of a large series of cases (usually 12 or more) obtained as fine needle aspiration and core biopsies, non-gynecological specimens and …Length not stated
- timely reviewTimely Review. Comprehensive review and/or critique of the literature paired with the authors’ experience of an organ system, clinical condition, or technology.Length not stated
Policy excerpts from the journal's websitePreprints
- Preprints
Free format submission offered. Model summary
Diagnostic Cytopathology now offers free format submission for a simplified and streamlined submission process.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1985
- ISSN
- 8755-1039
- Electronic ISSN
- 1097-0339
- Latest issue on the website
- Volume 54, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Diagnostic Cytopathology
What CAS zone is Diagnostic Cytopathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diagnostic Cytopathology is in Zone 4 of Medicine, and in Zone 4 of the minor category Medical Laboratory Technology / Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diagnostic Cytopathology?
The latest impact factor listed by LetPub is 0.93; CiteScore 2, h-index 90.
How long does peer review take at Diagnostic Cytopathology?
Based on the dates recorded on 91 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 51–103 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 25% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Diagnostic Cytopathology based?
Of the 24 board members whose country the journal's board page names, none are in mainland China; the countries named most often are India (3), Taiwan, China (2) and France (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Diagnostic Cytopathology?
According to LetPub and DOAJ records, Diagnostic Cytopathology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Diagnostic Cytopathology open access, and what is the APC?
Diagnostic Cytopathology is a hybrid journal. For open-access publication: APC about USD 3,920.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .